Sexual dysfunction in patients with allergic rhinoconjunctivitis

dc.contributor.authorKirmaz C.
dc.contributor.authorAydemir O.
dc.contributor.authorBayrak P.
dc.contributor.authorYuksel H.
dc.contributor.authorOzenturk O.
dc.contributor.authorDegirmenci S.
dc.date.accessioned2024-07-22T08:24:04Z
dc.date.available2024-07-22T08:24:04Z
dc.date.issued2005
dc.description.abstractBackground: Sexual dysfunction in chronic diseases has recently attracted attention owing to its impact on quality of life (QoL). Allergic rhinoconjunctivitis (ARC) affects QoL, causing limitations in many areas. However, there has not been research on changes in sexual function in patients with ARC. Objective: To report the effect of ARC and its treatment on sexual function in men and women. Methods: Forty-three sexually active patients with seasonal ARC aged 22 to 49 years were included in the study. The control group was composed of 40 healthy individuals aged 22 to 46 years. Conjunctival symptom scores (CSSs) and nasal symptom scores (NSSs) of patients with symptomatic ARC were determined, as were sexual function scores (SFSs) using the Female Sexual Function Index and the International Index of Erectile Function during allergen exposure in the pollination period and after treatment with oral desloratadine, 5 mg/d, for 30 days. The SFSs were evaluated in the control group. Results: The CSSs and NSSs significantly improved in treated ARC (P < .001). In women, Female Sexual Function Index results in symptomatic ARC were significantly lower than in treated ARC and controls (P = .003). In men, International Index of Erectile Function results in treated ARC (P = .001) and controls (P < .001) were significantly higher than in symptomatic ARC. Furthermore, correlation between improvement in CSSs and NSSs and that of SFSs was determined (P = .007 for women; P = .001 for men). Conclusion: Improvement in sexual function as a variable of QoL may accompany the treatment of symptoms in patients with ARC.
dc.identifier.DOI-ID10.1016/S1081-1206(10)61013-7
dc.identifier.issn10811206
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/19813
dc.language.isoEnglish
dc.publisherAmerican College of Allergy, Asthma and Immunology
dc.subjectdesloratadine
dc.subjecthistamine
dc.subjectadult
dc.subjectallergic conjunctivitis
dc.subjectallergic rhinitis
dc.subjectarticle
dc.subjectclinical article
dc.subjectcontrolled study
dc.subjectenvironmental exposure
dc.subjectfemale
dc.subjectfemale sexual function index
dc.subjecthuman
dc.subjectinternational index of erectile function
dc.subjectmale
dc.subjectpollination
dc.subjectpriority journal
dc.subjectquality of life
dc.subjectrating scale
dc.subjectsexual dysfunction
dc.subjectsexual function
dc.titleSexual dysfunction in patients with allergic rhinoconjunctivitis
dc.typeArticle

Files